Cargando…

Increased Oxidative Stress Markers in Acute Ischemic Stroke Patients Treated with Thrombolytics

One of the most common neurological disorders involving oxidative stress is stroke. During a stroke, the balance of redox potential in the cell is disturbed, and, consequently, protein oxidation or other intracellular damage occurs, ultimately leading to apoptosis. The pineal gland hormone, melatoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawluk, Hanna, Kołodziejska, Renata, Grześk, Grzegorz, Woźniak, Alina, Kozakiewicz, Mariusz, Kosinska, Agnieszka, Pawluk, Mateusz, Grzechowiak, Elżbieta, Wojtasik, Jakub, Kozera, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779811/ https://www.ncbi.nlm.nih.gov/pubmed/36555265 http://dx.doi.org/10.3390/ijms232415625

Ejemplares similares

The Potential Role of RANTES in Post-Stroke Therapy
por: Pawluk, Hanna, et al.
Publicado: (2023)

Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke
por: Pawluk, Hanna, et al.
Publicado: (2022)

The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke
por: Pawluk, Hanna, et al.
Publicado: (2020)

Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis
por: Pawluk, Hanna, et al.
Publicado: (2020)

Microbial Synthesis of (S)- and (R)-Benzoin in Enantioselective Desymmetrization and Deracemization Catalyzed by Aureobasidium pullulans Included in the Blossom Protect™ Agent
por: Kołodziejska, Renata, et al.
Publicado: (2021)

Pentraxin 3 as a Novel Marker in Cardiovascular Diseases?
por: Malinowski, Bartosz, et al.
Publicado: (2011)

The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target
por: Wołowiec, Anna, et al.
Publicado: (2023)

Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023)

Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke
por: Stemer, Andrew, et al.
Publicado: (2010)

Resveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism
por: Wiciński, Michał, et al.
Publicado: (2017)

Thrombolytic or endovascular therapy for acute ischemic stroke: Time is brain
por: Mijajlovic, Milija D.
Publicado: (2014)

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke
por: Yoo, Han Soo, et al.
Publicado: (2013)

Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke
por: Li, Lin, et al.
Publicado: (2017)

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
por: Poupore, Nicolas, et al.
Publicado: (2020)

Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study
por: Kędziora-Kornatowska, Kornelia, et al.
Publicado: (2010)

Acute Ischemic Stroke in a Child Successfully Treated with Thrombolytic Therapy and Mechanical Thrombectomy
por: Souto Silva, Renata, et al.
Publicado: (2019)

The Prognostic Value of High Platelet Reactivity in Ischemic Stroke Depends on the Etiology: A Pilot Study
por: Wiśniewski, Adam, et al.
Publicado: (2020)

Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke
por: Radecki, Ryan Patrick
Publicado: (2011)

Effects of Nursing Quality Improvement on Thrombolytic Therapy for Acute Ischemic Stroke
por: Liu, Zhuo, et al.
Publicado: (2018)

Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
por: Mohmand, Billal, et al.
Publicado: (2021)

Disruptions of Circadian Rhythms and Thrombolytic Therapy During Ischemic Stroke Intervention
por: Liu, Jennifer A., et al.
Publicado: (2021)

In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
por: Yang, Yilin, et al.
Publicado: (2023)

Review of Stroke Thrombolytics
por: Bivard, Andrew, et al.
Publicado: (2013)

The Usefulness of the Kurashiki Prehospital Stroke Scale in Identifying Thrombolytic Candidates in Acute Ischemic Stroke
por: Jang, Jieun, et al.
Publicado: (2014)

Potential Markers in Cardiac Hypertrophy?
por: Malinowski, Bartosz, et al.
Publicado: (2012)

Are in-Hospital Delays Important Obstacles in Thrombolytic Therapy Following Acute Ischemic Stroke?
por: Choi, Jay Chol, et al.
Publicado: (2007)

CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
por: Sillanpaa, Niko, et al.
Publicado: (2011)

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy
por: Kikule, Ilga, et al.
Publicado: (2022)

Development and Testing of Thrombolytics in Stroke
por: Nikitin, Dmitri, et al.
Publicado: (2021)

Design of a “Cobot Tactile Display” for Accessing Virtual Diagrams by Blind and Visually Impaired Users
por: Gill, Satinder, et al.
Publicado: (2022)

Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy
por: Sanders, Carolyn Breauna, et al.
Publicado: (2022)

Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke
por: Sivanandy, Palanisamy, et al.
Publicado: (2011)

Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis
por: Zhang, Chun-Yang, et al.
Publicado: (2018)

Improper Use of Thrombolytic Agents in Acute Hemiparesis Following Misdiagnosis of Acute Ischemic Stroke
por: Kim, Min Chan, et al.
Publicado: (2018)

Predictive Factors for Functional Outcomes After Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
por: Çetiner, Mustafa, et al.
Publicado: (2018)

Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need
por: Peña, Ike dela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d485e8aohmdf9s924jldlnpo84